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Toxins produced by Bacillus anthracis and
other microbial pathogens require functions of
host cell genes to yield toxic effects. Here we
show that low density lipoprotein receptor-
related protein 6 (LRP6), previously known to
be a coreceptor for the Wnt signaling pathway,
is required for anthrax toxin lethality in mamma-
lian cells. Downregulation of LRP6 or coexpres-
sion of a truncated LRP6 dominant-negative
peptide inhibited cellular uptake of complexes
containing the protective antigen (PA) carrier of
anthrax toxin moieties and protected targeted
cells from death, as did antibodies against epi-
topes in the LRP6 extracellular domain. Fluores-
cence microscopy and biochemical analyses
showed that LRP6 enables toxin internalization
by interacting at the cell surface with PA re-
ceptors TEM8/ATRand/orCMG2 to formamulti-
component complex that enters cells upon PA
binding. Our results, which reveal a previously
unsuspected biological role for LRP6, identify
LRP6 as a potential target for countermeasures
against anthrax toxin lethality.
INTRODUCTION
Anthrax, a lethal disease of humans and other animals
caused by the gram-positive spore-forming eubacterium,
Bacillus anthracis (Leppla, 2000; Bhatnagar and Batra,
2001; Collier and Young, 2003), has been the focus of
both biological interest and bioterrorism concerns. The
virulence of B. anthracis infection is produced by separate
complexes formed by interaction of a carrier protein, pro-
tective antigen (PA, 83 kDa) with lethal factor (LF, 90 kDa)
or edema factor (EF, 89 kDa) (Singh et al., 1989) moieties.During infection by B. anthracis, PA binds to receptors on
the cell surface and is cleaved by the protease furin,
releasing a 20 kDa fragment and enabling the residual
receptor-bound C-terminal 63 kDa PA peptide fragment
(PA63) to form heptamers which can interact with LF or
EF. After entering target cells, PA/LF and PA/EF com-
plexes translocate across the endosomal membrane into
the cytosol where they dissociate, allowing LF and EF to
exert their toxic effects (Leppla, 2000). LF is a Zn2+ prote-
ase that cleaves the amino terminus of nearly all MAPK
kinases (Duesbery et al., 1998; Vitale et al., 1998). EF is
a calmodulin-dependent adenylate cyclase that elevates
intracellular levels of cAMP, producing profound clinical
edema and impairing the immune response to infection
(O’Brien et al., 1985; Hoover et al., 1994).
Two distinct cell surface proteins act as receptors for
PA: ATR (anthrax toxin receptor) (Bradley et al., 2001;
Liu and Leppla, 2003), which is encoded by alternatively
spliced transcripts of the tumor endothelial marker 8
(TEM8) gene (Carson-Walter et al., 2001), and CMG2,
which has 60% identity with ATR and is encoded by cap-
illary morphogenesis gene 2 (Scobie et al., 2003). Low
density lipoprotein receptor-related protein 6 (LRP6) is
a member of a gene family encoding low-density lipopro-
tein receptors (LDLRs) that reside on the cell surface and
participate in endocytosis of their ligands (Stefansson
et al., 1995; Howell and Herz, 2001; Yu et al., 2001). As
a key component of a complex that mediates the trans-
duction of signals from secreted Wnt proteins to b catenin,
LRP6 functions in the regulation of embryogenesis and
cell proliferation (e.g., Pinson et al., 2000; Tamai et al.,
2000; Semenov et al., 2001). During experiments that
used expressed sequence tags (ESTs) to inactivate chro-
mosomal genes in human cell populations (Lu et al., 2004),
together with a phenotypic screen for cellular genes re-
quired for anthrax toxicity, we discovered that LRP6 inter-
acts with the anthrax toxin receptors TEM8/ATR and
CGM2 to promote entry into the cytoplasm of PA/receptor
complexes and consequently that LRP6 deficiency miti-
gates the effects of anthrax toxin. Our studies identifyCell 124, 1141–1154, March 24, 2006 ª2006 Elsevier Inc. 1141
Figure 1. Evidence that LRP6 Deficiency Mitigates Toxicity to PA + FP59
(A) Cytotoxicity of the naı¨ve M2182tTA and clone ATR43 to PA/ FP59. The MTT assay was performed as described in Experimental Procedures. The
values shown represent the mean and standard deviation, as defined by error bars in this and other figures.
(B) Effect of tetracycline on resistance of ATR43 to PA/FP59. Cells were seeded at a concentration of 5 103 cells/well (96-well plate) with or without
tetracycline (Tet, 1 mg/ml) and treated with PA (30 ng/ml or 3.7  1010 M) plus FP59 (50 ng/ml) for 2 days before being assayed by MTT. The values
shown represent the mean and standard deviation (bars).1142 Cell 124, 1141–1154, March 24, 2006 ª2006 Elsevier Inc.
LRP6 as a potential target for the prophylaxis and treat-
ment of anthrax cytotoxicity.
RESULTS
Isolation and Characterization of Cells
Showing Decreased Toxin Susceptibility
We designed a phenotypic screen aimed at discovering
cellular genes that specifically affect the actions of PA in
the pathway to anthrax toxicity. In these experiments,
we used a transactivated tetracycline (Tet)-controlled pro-
moter (Tet-off system) (Gossen and Bujard, 1992; Gossen
et al., 1995) on the lentiviral vector pLEST to activate anti-
sense transcription 40,000 human ESTs (Lu et al., 2004)
introduced into a population of M2182 human prostate
carcinoma cells. We then isolated clones resistant to kill-
ing by a mixture of PA and FP59, a fusion of the PA binding
domain of LF to the ADP ribosylation domain of Pseudo-
monas aeruginosa exotoxin A. As PA enables the entry
of FP59 into cells and exotoxin-A mediated lethality (Arora
and Leppla, 1992), we reasoned that cells made defective
in PA internalization by antisense expression of ESTs
would show decreased killing by PA + FP59.
Screening of a cell library having an estimated complex-
ity of 2  105 independent insertions of the pLEST con-
struct in chromosomes of M2182 cells yielded 73 colonies
resistant to PA + FP59, nine of which showed downregu-
lation of resistance by tetracycline. ATR43, a clone that
survived a PA concentration >25-fold the concentration
that was lethal in the parental cell line when combined
with 50 ng/ml of FP59 (Figure 1A), was selected for further
study. Growth of ATR43 cells for 48 hr in the presence of
Tet (1 mg/ml) decreased their ability to survive exposure
to the toxin while having little effect on growth of the pa-
rental line (Figure 1B).
Analysis of the PCR-amplified EST present in ATR43
revealed a single chromosomally integrated sequenceCthat corresponds to a 228 nt image clone (image clone
285207, accession number N66273) (Hillier et al., 1996)
annotated in GenBank as an intron located between exons
21 and 22 of the low-density lipoprotein receptor-related
protein 6 (lrp6) gene. This cDNA had been cloned in pLEST
30 to the Tet-regulated lentiviral promoter and in antisense
orientation relative to the promoter.
Decreased Expression of LRP6 Results
in Toxin Resistance
Western blot analysis of ATR43 cell extracts (Figure 1C) in-
dicated decreased intensity of bands migrating at the pre-
viously identified positions of LRP6 monomer and dimer
(Liu et al., 2003a), as detected with murine monoclonal an-
tibody directed against an epitope present in both LRP6
and the related protein, LRP5. We confirmed the identity
of these bands as LRP6 monomers and dimers by electro-
phoresis of lysates containing an N-terminally-tagged
Flag-LRP6 protein in SDS-PAGE in the presence of the re-
ducing agent b mercaptoethanol (b ME), followed by im-
munoblotting with anti-Flag antibody (Figure 1D); the two
highly reproducible faint bands migrating more slowly
than the Flag-tagged LRP6 dimer (Figure 1C) may repre-
sent multimeric forms of LRP6. The biological effects of re-
duction of LRP6 protein in ATR43 were evident also from
the observed impairment of the cellular response of this
clone to Wnt, as indicated by sharply decreased activity
of a b catenin-regulated promoter on the Super8XTOP-
flash reporter plasmid (Veeman et al., 2003), which was
introduced into this cell clone (Figure 1E).
While the above experiments argue strongly for the role
of LRP6 in the phenotype observed for ATR43 cells, as-
signment of the EST sequence that mediates tetracy-
cline-dependent regulation of toxin resistance in ATR43
cells to a region of the lrp6 gene that has been annotated
in GenBank as an intron prompted additional studies to fur-
ther establish the causal role of LRP6 deficiency in toxin(C) Immunoblot analysis of lysates from naı¨ve M2182tTA and mutant clone ATR43 cells using murine monoclonal antibody directed against human
LRP5/6. a tubulin bands were measured in Western blots as internal controls. In SDS-PAGE gels, LRP6 appeared in both monomer (*) and dimer (**)
forms in the presence of the reducing agent, b mercaptoethanol (b ME).
(D) Confirmation of the molecular nature of both monomer (*) and dimer (**) bands of LRP6 proteins. N-terminal-tagged Flag-LRP6 was transfected
into 293T cell, and the expressing lysates from transiently transfected cells electrophoresed under SDS-PAGE conditions in the presence of b ME
were probed in immunoblots using anti-Flag monoclonal antibody.
(E) Effect of LRP6 deficiency on cellular response to Wnt activation. The data shown are the summed results of three independent experiments. The
values shown represent the mean and standard deviation (bars). siRNA-sc refers to a scrambled sequence siRNA control.
(F) Effect of LRP6 deficiency induced in naı¨ve cells. The EST identified in the ATR43 mutant was reintroduced into pLEST in the antisense orientation.
Pooled populations of infected M2182tTA clones in 6-well plates were treated with PA/FP59 and photographed by microscopy at a magnification of
100 . M2182/pLEST-LIB refers to EST library in M2182 cells serving as a control.
(G) Effect of lrp6-specific siRNA on transcript abundance. lrp6 transcripts were measured by quantitative RT-PCR and normalized to b actin mRNA.
Filled-in bars indicate transcript abundance compared with wild-type M2182. Each data point represents an average of three repeats. The values
shown represent the mean and standard deviation (bars).
(H and I) Immunoblot assays of lysates of M2182 cells expressing siRNAs directed against lrp6 transcripts. Antibodies used for detection were rabbit
polyclonal antibody H300 (H) against human LRP6 protein and murine monoclonal antibody against human LRP5/6 (I). Anti-a-tubulin antibody was
used to calibrate loading of lysates on gels. Both monomer (*) and dimer (**) forms of LRP6 protein bands are shown. Antibody specificity was con-
firmed by blotting the same membrane using antibody that had been preabsorbed with an excess of the peptide used as the immunogen (I, middle).
(J and K) Cytotoxicity of PA + FP59 in M2182 cells treated with siRNAs (J) and in M2182/siRNA3 cells expressing LRP6 protein (K). Cell viability was
assessed as described in Figure 1A. Two individual M2182/siRNA3 clones expressing the mutant LRP6m3 construct were subjected to the PA + FP59
toxin assay (K). A clone containing the expression vector alone (pcDNA3.1) was included as a control for effects of the extended procedure per se on
siRNA-modulated interference with toxicity.ell 124, 1141–1154, March 24, 2006 ª2006 Elsevier Inc. 1143
Figure 2. Effect of LRP6 on PA Binding and Internalization
(A) Effect of LRP6 deficiency on mouse macrophage sensitivity to PA + LF. pLENTI-SUPER constructs expressing siRNAs directed against murine
lrp6 transcripts were introduced into RAW264.7 cells by transfection, and the cells acquiring the vector were selected by blasticidin and pooled for
cytotoxicity assays. Controls were RAW264.7 cells expressing human lrp6 siRNA1, which shares no homology with the mouse lrp6 sequence, and the
naı¨ve RAW264.7 cells not subjected to transfection. Cells at 1 103 cells per well in 96-well plates were treated with serially diluted PA and 500 ng/ml
of LF for 2 days. Cell viability was assessed using MTT assay as described in Figure 1A. This experiment was repeated five times with separate trans-
fection assays, and similar quantitative differences in experimental and control samples were observed.
(B and C) Western blot analysis of bound (B) and internalized (C) PA in different cells was conducted following the protocol as described in Exper-
imental Procedures. PA83 is the full-length form of PA (83 kDa), and the oligomer represents the heptamer of PA63. a tubulin abundance was mea-
sured as an internal control.1144 Cell 124, 1141–1154, March 24, 2006 ª2006 Elsevier Inc.
resistance. First, a plasmid (pATR43) containing cDNA of
image clone 285207 that was newly inserted into the pLEST
vector in antisense orientation with respect to the Tet-reg-
ulated promoter was introduced into naı¨ve M2182tTA cells.
As was observed for ATR43, these cells showed decreased
sensitivity to PA + FP59 (Figure 1F), confirming the role of
the EST sequence in toxin resistance. The effects of inacti-
vating lrp6 on the sensitivity of M2182 cells to PA + FP59
were further confirmed in cell clones that stably produced
21–23 nt siRNAs complementary to three different exonic
sequences of lrp6 mRNA. Downregulation of lrp6 tran-
scripts by two of these siRNAs, siRNA1 and siRNA3, was
observed by quantitative RT-PCR (Figure 1G) along with
(1) reduction of the steady-state level of LRP6 protein as in-
dicated by the summed densities of LRP6 monomer and
multimer bands (Figures 1H and 1I); (2) an impaired cellular
response to Wnt activation (Figure 1E); and (3) reduced
toxin susceptibility (Figure 1J). Preabsorption of the pep-
tide employed as immunogen resulted in disappearance
of the Western blot signals (Figure 1I, middle panel), al-
though the ratio of LRP6 monomer and dimer varied in dif-
ferent experiments and for different LRP6 antibodies.
That the observed siRNA effects on toxin-induced le-
thality resulted from inhibition of LRP6 function was further
confirmed by concurrent overexpression of full-length lrp6
cDNA in two independent toxin-resistant clones (Figure1K;
M2182/siRNA3 carrying pLRP6m3-4 or pLRP6m3-8 ver-
sus M2182/siRNA3 carrying pcDNA3.1 vector alone). In
these experiments, we created silent mutations at seven
sites in the 21-nucleotide sequence targeted by the siRNA
to prevent siRNA3 inhibition of the overexpressed lrp6
cDNA. Using a fixed concentration of FP59 (50 ng/ml),
the calculated values of EC50 (effective concentration of
PA required to kill 50% of cells tested) were increased 4.3-
to 5.1-fold (calculated values for M2182, M2182/siRNA3_
pLRP6m3-4, M2182/siRNA3_pLRP6m3-8, and M2182/
siRNA3_pcDNA3.1 are 3  1011 M, 5.4  1010 M, 4.5 
1010 M, and 2.3  109 M, respectively).
LRP6 Deficiency Results in Impaired Binding
and Internalization of PA
The known cell-surface location and previously elucidated
biological roles of LRP6 suggested that LRP6 deficiency
might alter toxin lethality by impairing PA functions. To
test this hypothesis, we examined the effects of lrp6-spe-
cific siRNAs on the ability of native anthrax toxin (i.e., PA +LF) to kill macrophages, which are a natural target for LF.
Three siRNAs corresponding to sequences of the murine
lrp6 gene were inserted in the pLENTI-SUPER vector
and expressed stably in the murine macrophage cell line
RAW264.7. Controls were nontransfected RAW264.7 cells
and cells expressing siRNA1 directed against a human
lrp6 sequence absent in the mouse gene. As shown in
Figure 2A, MTT assay indicated increased survival in
each of the three mouse-sequence-specific lrp6 siRNA
pools of clones exposed to PA + LF.
Western blot analysis of lysates from M2182 cells made
resistant to toxin by either siRNA or antisense RNA against
lrp6 transcripts showed a decrease in 83 kDa PA mono-
mer bound to the cell surface (Figure 2B) and reduction
of an SDS-resistant oligomeric form of PA that character-
istically survives proteolytic treatment when cell cultures
exposed to toxin complexes at 4ºC are shifted to 37ºC and
the toxin complexes are internalized (Liu et al., 2003a)
(Figure 2C). Additionally, deconvolution fluorescence mi-
croscopy using Alexa 488-labeled PA indicated that the
abundance of PA both at the cell surface (Figure 2D) and
in the cytoplasm (Figure 2E) was reduced in all LRP6-
deficient clones examined, consistent with our biochemi-
cal evidence of decreased PA binding and internalization.
Internalized PA colocalized with the early endosomal
marker EEA1 (data not shown), in agreement with evi-
dence that surface bound PA complexes are translocated
into early endosomes after internalization (Leppla, 1995).
The Intracellular Domain of LRP6 Is Essential
for PA-Mediated Internalization and Toxin Lethality
The data presented above suggest that deficiency of
LRP6 decreases both binding and internalization of PA.
An LRP6 mutant protein (i.e., LRP6DC) that lacks most
of the cytoplasmic domain (Figure 2F) and has been re-
ported to have dominant-negative effects on Wnt signal-
ing mediated by the coexisting wild-type LRP6 protein
(Tamai et al., 2000) and an additional truncated LRP6 mu-
tant protein that we expressed from pcDNA3.1 were
tested for their ability to block PA-mediated cytotoxicity
of FP59 in M2182 cells. Cell populations expressing each
LRP6DC mutant protein were treated with PA (50 ng/ml) +
FP59 (50 ng/ml) for 2 days, followed by extended growth
on toxin-free medium. Whereas no survivors were ob-
served among naı¨ve M2182 cells or cells transfected with
pcDNA3.1, colonies were seen within several days in cells(D) For PA binding assay, cells were incubated with Fluor 488-labeled PA for 1 hr at 4ºC before being examined by deconvolution microscopy following
the protocol described in Experimental Procedures. Scale bar = 2.8 m.
(E) For PA internalization assays, cells were incubated with Fluor 488-labeled PA (1 mg/ml) for 45 min at 37ºC followed by deconvolution microscopy.
Scale bar = 2.8 m.
(F) Schematic structure of dominant-negative mutant LRP6DC and wild-type LRP6 proteins. LRP6DC was generated by deleting amino acid residues
from 1440 onward (Tamai et al., 2000), as described in Experimental Procedures.
(G) Effect of LRP6DC production on cellular response to Wnt activation. Luciferase reporter gene assay was carried out as in Figure 1E. The data
shown are the averaged results of three independent experiments. The values shown represent the mean and standard deviation (bars).
(H) Cytotoxicity assay of M2182 expressing LRP6DC, pLRP6DC-1, and pLRP6DC-8. Cell viability was assessed as described in Figure 1A.
(I and J) Western blot analysis of bound (I) and internalized (J) PA in LRP6DC mutants. PA binding and internalization assays were carried out as de-
scribed in Experimental Procedures using anti-PA monoclonal antibodies. a tubulin was used as an internal control.Cell 124, 1141–1154, March 24, 2006 ª2006 Elsevier Inc. 1145
Figure 3. Specificity of LRP6 Effect on
Cell Susceptibility to Anthrax Toxin
(A) Effect of Axin production on cellular
response to Wnt activation. Cells in 6-well
plates (40%–70% confluence) were transiently
transfected with the following three DNAs:
pcDNA3.1-AxinMyc (2 mg/well) or pcDNA3.1
(2 mg/well); Super8XTOPflash (1 mg/well); and
pcDNA-lacZ plasmid (0.1 mg/well). Luciferase
reporter gene assay was carried out as in
Figure 1E. The data shown are the averaged re-
sults of three independent experiments. The
values shown represent the mean and stan-
dard deviation (bars).
(B) Cytotoxicity assay of M2182-expressing
Axin. Cells transfected with the Axin expression
construct as in Figure 3A were subjected to
the PA/FP59 toxin assay. The values shown
represent the mean and standard deviation
(bars).
(C and D) Assay of ligand-induced EGF recep-
tor (EGFR) degradation. (C) EGFR degradation
in M2182 cells and its LRP6-deficient mutants,
ATR43, and M2182/siRNA3. (D) Effects of
overexpression of VPS4, VPS4 (E228Q), and
TSG101 (M95A) on EGF-induced EGFR degra-
dation. M2182 cells were transfected in 6-well
plates with pcDNA-EGFR (200 ng/well) along
with one of the following: VPS4, VPS4 (E228Q),
or TSG101 (M95A) (1 mg/well for each of the
three). Assays were performed as described
in Experimental Procedures.
(E) Cytotoxicity assay of M2182 expressing
VPS4, VPS4 (E228Q), or TSG101 (M95A). Cells
transfected with different expression con-
structs, as in Figure 3D, were subjected to
the PA/FP59 toxin assay. The values shown
represent the mean and standard deviation
(bars).expressing the pLRP6DC proteins (data not shown). Ran-
domly picked clones from transfected cells containing
the LRP6DC expression constructs were expanded to
generate the M2182/pLRP6DC-1 and M2182/pLRP6DC-
8 cell lines; assay of b catenin in these lines showed
sharply reduced Wnt signaling (Figure 2G), confirming
the dominant-negative effects of the LRP6DC proteins.
Both clonal lines showed a dramatic and highly reproduc-
ible decrease in killing by PA + FP59 (Figure 2H). More-
over, whereas binding of the 83 kDa PA monomer to the
cell surface was not detectably affected by overexpres-
sion of LRP6DC mutant proteins (Figure 2I), PA internaliza-
tion, as monitored by the presence of PA oligomer after
shift of the cell culture to 37ºC, was impaired (Figure 2J).
These results argue strongly that LRP6 plays an essential
role in accomplishing the internalization of PA and con-
sequently in conferring cellular susceptibility to anthrax
toxin. Moreover, the observed dominant-negative effects
of the LRP6DC on PA-mediated cell death imply that the
intracellular domain of LRP6, unlike the intracellular do-
main of the PA receptor, ATR/TEM8 (Liu and Leppla,
2003), is essential for toxin lethality.1146 Cell 124, 1141–1154, March 24, 2006 ª2006 Elsevier Inc.Disruption of Wnt Signaling or of Generalized
Mechanisms of Endocytic Trafficking
Does Not Impair Toxin Lethality
Is disruption of Wnt signaling a mechanism underlying the
resistance to PA-mediated toxin lethality we observed in
cells defective in LRP6 function? To address this question,
we examined the effects of Axin, which regulates Wnt
signaling downstream of entry of the Wnt/receptor com-
plex into cells (Zeng et al., 1997; Itoh et al., 1998; Willert
et al., 1999), on the resistance of M2182 cells to PA +
FP59. Whereas adventitious expression of Axin prevented
induction of b catenin following addition of Wnt protein to
cell cultures (Figure 3A), susceptibility to PA/FP59 toxin
was unaltered by Axin expression (Figure 3B), indicating
that interference with Wnt signaling per se does not result
in toxin resistance.
Whether mitigation of anthrax toxin lethality by LRP6 de-
ficiency is associated with more generalized effects on en-
docytic trafficking was addressed firstly by determining if
LRP6-deficient cells show normal internalization and en-
docytic trafficking of a prototypical cell-surface receptor,
theepidermalgrowth factor receptor (EGFR), andsecondly
Figure 4. Binding of LRP6 Extracellular Domain to TEM8 and CMG2
(A) 293T cells were transfected with LRP6N-Myc. Cell medium containing LRP6N-Myc protein was incubated with PA83 on ice for 30 min before being
mixed with agarose-conjugated anti-c-Myc antibody or G protein agarose conjugated with PA rabbit polyclonal antibody. After incubation for an ad-
ditional 3 hr on a rotator in a cold room, the agarose beads were washed and subjected to immunoblot analysis.
(B) 293T cells were transfected with Flag-LRP6, TEM8-HA, or both. Cell lysates were treated by addition of anti-HA-conjugated agarose beads or anti-
Flag-conjugated affinity gel. The precipitated proteins were then subjected to immunoblot analysis probed with anti-Flag antibody conjugated with
horseradish peroxidase (HRP) (top) or anti-HA-HRP (bottom).
(C) 293T cells were transfected with LRP6N-Myc, TEM8-HA, or both. Cell lysates plus medium were treated by addition of anti-HA-conjugated or anti-
c-Myc conjugated agarose beads. The precipitated proteins were then subjected to immunoblot analysis probed with anti-c-Myc-HRP.
(D) 293T cells were transfected with LRP6N-Myc, CMG2-EGFP, or both. Cell lysates plus medium were treated with either anti-GFP-conjugated aga-
rose beads or anti-c-Myc-conjugated agarose beads. The precipitated proteins were then subjected to immunoblot analysis probed with anti-c-Myc-
HRP (top) or anti-GFP-HRP (bottom).
(E) 293T cells were transfected with LRP6N-Myc, Myc-LRP6DN, TEM8-HA, or a combination of two of them. Cell lysates combined with medium were
treated with anti-HA-conjugated agarose beads before being subjected to immunoblot analysis probed with anti-c-Myc-HRP.
(F) 293T cells were transfected with LRP6N-Myc, TEM8-HA, or both. Cell lysates combined with medium were treated with anti-HA-conjugated
agarose beads in the presence or absence of PA (0.5 mg/ml) before being subjected to immunoblot analysis probed with anti-c-Myc-HRP. Chemi-
luminescence of Western blot bands was quantitated by using the VersaDoc Imaging System (Model 1000, Bio-Rad) and its software (Quantity
One, Version 4.5.1).by investigating whether cells having broad defects in en-
docytic trafficking exhibit resistance to toxin lethality. We
observed that epidermal growth factor-induced internali-
zation and degradation of EGFR was similar in parental
M2182 cells, in clone ATR43, and in cells made toxin resis-
tant by siRNA directed against LRP6 (Figure 3C). Con-
versely, cells that overexpress the mutant TSG101 or
VPS4 proteins and consequently are broadly defective in
endocytic trafficking (Bishop and Woodman, 2001; Strack
et al., 2003; Lu et al., 2003) showed the expected abnor-
mality of EGFR internalization/degradation (Figure 3D)Cbut unchanged lethality to PA + FP59 (Figure 3E). Thus,
LRP6 deficiency does not result in a generalized defect in
endocytic trafficking, and defective endocytic trafficking
per se is not sufficient to mitigate toxin effects.
LRP6 Protein Interaction with PA Receptors TEM8
and CMG2 Is Required for Toxin Internalization
Multiple coimmunoprecipitation (co-IP) experiments
showed interaction between LRP6 and both of the previ-
ously identified cellular receptors for PA (i.e., TEM8
and CMG2) but no direct association of LRP6 with PAell 124, 1141–1154, March 24, 2006 ª2006 Elsevier Inc. 1147
Figure 5. LRP6 Effects on Internalization and Localization of PA and Its Receptors
(A and B) Deconvolution microscopy images (three independent image fields for each) showing the colocalization of Flag-LRP6 (red) and PA oligo-
mers (green). M2182 cells were first transfected with Flag-LRP6 two days prior to fluorescence microscopy. Cells were incubated without PA (A) or
with Fluor-488-conjugated PA (1 mg/ml) at 37ºC for 45 min (B). Flag-LRP6 protein labeled by Fluor-594 (red) is shown in the left panels (A and B). The
PA oligomer signal (green) is shown in the middle panels. The right panels show the merged images, including DAPI nuclear staining (blue). Scale bar
(A and B) = 2.8 m.
(C) Deconvolution microscopy images showing colocalization of Fluor-594-labeled TEM8-HA (red) with Fluor-488-conjugated PA (1 mg/ml) (green)
after cells were incubated with PA (1 mg/ml) for 45 min at 37ºC (scale bar = 2.8 m). The top and bottom panels show two independent fields. The right
panels show the merged images, including DAPI nuclear staining (blue).
(D) Deconvolution microscopy images showing the colocalization of Flag-LRP6 (red) and CMG2-EGFP (enhanced green fluorescent protein) after
cells were incubated with PA (1 mg/ml) for 45 min at 37ºC. Scale bar = 2.8 m.
(E and F) M2182 cells transfected with TEM8-HA or CMG2-EGFP were first incubated with or without PA (1 mg/ml) at 37ºC for 45 min before decon-
volution microscopy.
(E) Microscopy images showing aggregates (white arrows) of internalized TEM8-HA (red) in M2182 (top panels) or M2182/siRNA1 cells (bottom
panels) in the absence (left panels) or presence (right panels) of PA. Scale bar = 5.6 m.1148 Cell 124, 1141–1154, March 24, 2006 ª2006 Elsevier Inc.
(Figure 4A). In these experiments, the C-terminal Myc-
tagged extracellular domain of LRP6 (LRP6N-Myc) was
harvested from 293T cell growth medium and incubated
with PA or with lysates containing HA-tagged TEM8
(TEM8-HA) or enhanced green fluorescent protein-tagged
(EGFP-tagged) CMG2 (CMG2-EGFP); 293T lysates ex-
pressing N-terminal Flag-tagged full-length LRP6 (Flag-
LRP6) were also examined by co-IP assay. LRP6 was
detected in precipitates of TEM8-HA (Figure 4B, top), and
TEM8 was observed in precipitates of Flag-LRP6 (Fig-
ure 4B, bottom). Similar co-IP experiments carried out us-
ing TEM8-HA and LRP6N-Myc, which contains only the
extracellular domain of LRP6 (i.e., LRP6N), indicated that
this domain is sufficient for interaction with TEM8 (Fig-
ure 4C). In additional experiments, we observed LRP6N
in precipitates of CMG2-EGFP (Figure 4D, top) and found
CMG2 in precipitates containing LRP6N-Myc (Figure 4D,
bottom). However, we observed no interaction between
either TEM8 or CMG2 and an LRP6-truncated protein
lacking the extracellular domain (Figure 4E). As the precip-
itated bands from co-IP experiments that detected the
interaction of LRP6 and PA receptors were faint in com-
parison with bands in the positive control lanes (Figures
4B–4D), we suspect that efficient interaction between
LRP6 and PA receptors may involve accessory protein(s)
that were not overexpressed in these experiments and
which thus may be present in limiting amounts. Interest-
ingly, while interaction binding of the LRP6 extracellular
domain to TEM8 did not require PA, PA expression en-
hanced this interaction (Figure 4F); we have not observed
enhancement of the LRP6-CMG2 interaction by PA (data
not shown).
As LRP6 initiates Wnt signaling when it enters cells to-
gether with other members of a Wnt-based complex
(Mao et al., 2001), we hypothesized that LRP6 may func-
tion similarly to promote internalization of PA and its re-
ceptors; deconvolution fluorescence microscopy experi-
ments provided evidence of just such a role. As has
been observed previously (Cong et al., 2004), in the ab-
sence of PA, deconvolution microscopy showed that
Alexa Fluor-594-stained (red) Flag-labeled LRP6 was
present mainly in the cytoplasm as well as on the cell
surface (Figure 5A). Addition of PA altered the location of
internalized red fluorescent LRP6, resulting in its polar ag-
gregation within the cytoplasm (Figure 5B). Furthermore,
green fluorescence-labeled PA colocalized with cytoplas-
mic LRP6 (Figure 5B) and also with internalized TEM8
(Figure 5C). We were not able routinely to overexpress
LRP6 concurrently with either TEM8 or CMG2 in the
same cells (M2182); however, in rare instances when con-
current overexpression of both Flag-LRP6 and CMG2-
EGFP was achieved, colocalization of LRP6 and CMG2
was observed in cells treated with PA (e.g., Figure 5D).
Expression of siRNA directed against LRP6 or dominant-Cnegative LRP6DC prevented the occurrence of cytoplas-
mic aggregates of Alexa Fluor-594-stained TEM8-HA
(Figure 5E) and EGFP-labeled CMG2 (Figure 5F), which
normally were observed after incubation of cells with PA
for 45 min at 37ºC (Figure 5E, top panels)—providing fur-
ther evidence that the PA-mediated internalization of
TEM8 and CMG2 is dependent on LRP6. Collectively,
our immunoprecipitation and fluorescence microscopy
results argue strongly that LRP6 forms a complex with
PA receptors that accomplishes the translocation of PA
and the bound toxin moieties into the cytoplasm.
LRP6 Antibodies Protect Cells
from Anthrax Cytotoxicity
We generated rabbit polyclonal antibodies against two
synthetic peptides that correspond to different segments
of the extracellular domain of LRP6 and tested these anti-
bodies (N204, directed against amino acids 204–223, and
N251, directed against amino acids 515–534) (Figure 6A)
for their ability to protect RAW264.7 macrophages from
the lethal effects of anthrax toxin (PA + LF). Dosage-
dependent increased survival was observed for cells
treated with N251, whereas antibody N204 provided no
detectable protection from toxin killing (Figure 6B). Signif-
icantly, protection by antibody to N251 was partially re-
versed by the addition of peptide N251 but not by N204
(Figure 6C). H300, a commercially available rabbit poly-
clonal antibody generated against a LRP6 human protein
fragment (amino acids 1314–1613) that includes a se-
quence of the cytoplasmic domain as well as segments
of the extracellular and transmembrane domains (Fig-
ure 6A), also provided dosage-dependent protection
against killing by PA + LF (Figure 6D).
DISCUSSION
Role of LRP6 in Anthrax Toxicity
Using antisense RNA generated intracellularly against a li-
brary of ESTs to inactivate chromosomal genes globally in
populations of human cells plus an experimental strategy
that selected cell clones resistant to the actions of cyto-
toxins, we identified genes whose functional inactivation
is causally related to toxin resistance. This approach un-
covered lrp6, a member of a gene family encoding low-
density lipoprotein (LDL) receptor-related proteins (LRPs)
that reside on the cell surface and participate in the deliv-
ery of a variety of ligands into the cytoplasm (Orth et al.,
1992; Kounnas et al., 1995; Stefansson et al., 1995; Ho-
ward et al., 1996; Li et al., 2001). The results reported
here indicate that the LRP6 protein, which previously
has been known principally as a mediator of the Wnt sig-
naling pathway, has a hitherto unsuspected role in the de-
livery of anthrax toxins into cells.(F) Microscopy images showing aggregates (white arrows in four images of top right panels) and localization of CMG2-EGFP (green) in M2182 (top
panels) or M2182/pLRP6DC-1 (bottom panels) without (left panels) or with (right panels) PA. Four independent image fields are used for each panel.
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Figure 6. Effect of LRP6 Antibodies on Cytotoxicity of PA Plus LF
(A) Peptides used as immunogens to produce the antibodies. H300 is a rabbit polyclonal antibody raised against C-terminal of human LRP6 (1314–
1613). N251 and N204 are rabbit polyclonal antibodies raised against small peptides targeting different segments of LRP6 extracellular domain.
(B and C) Effects of LRP6 N251 and N204 on killing of RAW264.7 cell by PA/LF. Cell viability and the specificity of antibody protection (C) were as-
sessed as described in Experimental Procedures. The antibody concentration is the relative concentration of bleed (1 = 4.88E+7  dilution). The
values shown represent the mean and standard deviation (bars).
(D) Effect of LRP6 commercially available antibody H300 and rabbit polyclonal antibody raised against Cyclin E (M-20) (both from Santa Cruz Bio-
technology, Inc) as a control. The methods used are the same as above (Figure 6B). The values shown represent the mean and standard deviation
(bars).The role of LRP6 in PA-mediated toxigenicity was
confirmed by multiple lines of evidence: (1) regulation
of the toxin-resistance phenotype in clone ATR43 by tetra-
cycline (Figure 1B); (2) reproduction of the toxin-resis-
tance phenotype by antisense expression of the lrp6
EST in naı¨ve cells (Figure 1F); (3) reproduction of the toxin-
resistance phenotype by siRNA corresponding to se-
quences in the lrp6 open reading frame (ORF) and partial
reversal of this effect by overexpression of LRP6 protein
containing silent mutations that make it nonsusceptible
to inhibition by the siRNA (Figures 1J and 1K); (4) creation
of toxin resistance by expression of a dominant-negative
truncated LRP6 mutant protein lacking the cytoplasmic
domain of the protein (Figure 2H); (5) protection of cells
from anthrax toxicity by antibodies directed against
epitopes in the LRP6 extracellular domain (Figure 6); (6)1150 Cell 124, 1141–1154, March 24, 2006 ª2006 Elsevier Inc.biochemical evidence and deconvolution immunofluores-
cence microscopy results showing reduced internalization
of PA in ATR43 cells and in cells expressing siRNAs
directed against lrp6 mRNA (Figure 2); and (7) our demon-
stration using both fluorescence microscopy and immu-
noprecipitation approaches that the LRP6 protein in-
teracts with the PA receptors, TEM8 and CMG2, and
controls PA-triggered internalization of the receptors (Fig-
ures 4 and 5).
Biological Functions of LRP6 and Related Proteins
LDL receptors and LDL receptor-related proteins (LRPs)
are prototypes of macromolecules that interact with and
deliver ligands into cells via endocytosis (Schneider and
Nimpf, 2003). LRP6 differs from other members of its fam-
ily in that it contains a unique pattern of repeats of the
Figure 7. Model for LRP6-Promoted Internalization of Multicomponent Complex Containing TEM8/ATR and/or CMG2
LRP6 is proposed to act as a coreceptor for PA through its binding to TEM8/ATR and/or CMG2. PA addition triggers the internalization of this com-
plex, which delivers PA and associated toxin molecules into cells.epidermal growth factor receptor (EGFR) and LDL recep-
tor (LDLR) sequences in the extracellular domain (Brown
et al., 1998). A notable characteristic of LRP proteins is
their multifunctional nature. For example, LRP1 functions
as a receptor for apoE-rich remnant lipoproteins, for lipo-
protein lipase, for a 2-macroglobulin/protease com-
plexes, for plasminogen activator/inhibitor complexes,
for the active protease tissue-type plasminogen activator,
and for the surface binding domain of exotoxin A from
Pseudomonas aeruginosa (Willnow and Herz, 1994). Our
finding that LRP6 acts as a coreceptor to promote inter-
nalization of the PA component of anthrax toxin in addition
to its previously known role in Wnt signaling indicates that
LRP family proteins act more broadly in mediating the
pathogenic effects of microbial toxins. Possibly related
to our findings are results of DNA membrane array-based
experiments showing that exposure of macrophages to
the anthrax lethal toxin perturbs transcription of a variety
of genes regulated by GSK-3b—including some impli-
cated in Wnt signaling (Tucker et al., 2003).
Interestingly, the possibility that LRP1 and LRP6 can
interact functionally is suggested by recent evidence (Zil-
berberg et al., 2004) that LRP1 can sequester human Fz1
to disrupt the receptor/coreceptor complex formation and
repress canonical Wnt signaling, raising the possibility
that LRP6 may also modulate exotoxin A internalization.
LRP5, another member of the LRP family that has 71%
amino acid sequence identity to human LRP6, has also
been implicated in Wnt signaling (Tamai et al., 2000); how-
ever, LRP5 has distinct effects on bone accrual and eyeCdevelopment (Gong et al., 2001), and its presence does
not mitigate either the embryonic lethality of LRP6 null mu-
tations (Pinson et al., 2000) or the effects of LRP6 defi-
ciency on anthrax toxicity (the studies reported here).
The EST library fragment (i.e., image clone 285207)
identified in ATR43 cells corresponds to a sequence anno-
tated as being present in an intron of human lrp6 RNA.
While the occurrence of an apparently intronic fragment
in the widely used EST library may indicate contamination
of the library by genomic DNA, interference with LRP6
function by antisense RNA directed against this image
clone sequence suggests that it may in fact be exonic.
Analysis using the Human BLAT Search program (http://
genome.ucsc.edu/cgi-bin/hgBlat) indicated that the EST
that constitutes image clone 285207 corresponds also
to a sequence of the noncoding strand of an intron of a
Bcl-2-like gene (Bcl2L14).
Mechanistic Model for LRP6 Effects
on Toxin Lethality
The data reported here suggest the following model for the
role of LRP6 in anthrax toxicity (Figure 7). Independently of
the presence of PA, LRP6 protein at the cell surface is ca-
pable of interacting with two proteins previously identified
as PA receptors: TEM8/ATR and CMG2 (Bradley et al.,
2001; Scobie et al., 2003). Our data suggest that LRP6 de-
ficiency reduces PA binding to the cell surface (Figure 2B)
and also indicate that PA addition enhances binding of
LRP6 to the PA receptors. Upon addition of PA, a complex
containing PA, LRP6, and the PA receptors TEM8 orell 124, 1141–1154, March 24, 2006 ª2006 Elsevier Inc. 1151
CMG2 is formed and then internalized together with the
associated toxin moieties, LF or EF. This model is consis-
tent with earlier evidence that neither TEM8 nor CMG2 is
sufficient to carry toxin into the cells. The essential role
of LRP6 in enabling entry of receptor bound anthrax toxin
into cells parallels its previously demonstrated role in Wnt
pathway signaling (Mao et al., 2002). In that case, the
transmembrane protein Kremen2 forms a ternary complex
with the Wnt antagonist DKK-1 and LRP6, triggering
LRP6-mediated endocytosis of all three components
and consequent modulation of Wnt/b-catenin signaling.
Whether other cellular proteins are included in the PA/re-
ceptor/coreceptor complex and the stoichiometry of com-
plex formation currently is not known.
Our observation of perinuclear localization of adventi-
tiously expressed Flag-tagged LRP6 in M2182 cells (Fig-
ure 5) is consistent with recent independent evidence
that LRP6 can exist intracellularly in the perinuclear region
as well as at the plasma membrane of 293T cells (Cong
et al., 2004). Addition of PA increased the abundance of
cytoplasmic LRP6 and altered its location, producing po-
lar aggregates that colocalize with PA (Figure 5B). The
ability of antibodies against LRP6 extracellular domains
to protect cells from anthrax toxin killing (Figure 6) argues
that at least some of the LRP6 protein that colocalizes with
PA in the cytoplasm is derived from the cell surface. The
ring-shaped heptamer structure generated by spontane-
ous oligomerization of receptor bound PA (i.e., the pre-
pore) (Milne et al., 1994) is responsible for carrying EF or
LF into early endosomes, where PA heptamers form an
aqueous transmembrane channel that mediates trans-
location of EF and LF to the cytosol (Blaustein et al.,
1989). Whether LRP6 and the PA receptors are involved
mechanistically in the formation of the prepore structure
has not been determined.
Our discovery of the role of LRP6 in anthrax toxicity and
the demonstration that antibodies directed against the ex-
tracellular domain of LRP6 can protect cells grown in cul-
ture against killing by anthrax toxin suggest that the immu-
nological targeting of LRP6 may prove useful in protecting
against the effects of accumulated toxin during the late
stages of anthrax disease when antibacterial methods
normally are no longer of therapeutic value.
EXPERIMENTAL PROCEDURES
Cell culture, construction and screening of cDNA libraries, and con-
struction and cloning of expression vectors have carried out using
variations of methods reported previously (Lu et al., 2004); these are
described in detail in Supplemental Data.
Toxin Treatment and Cell Viability Assay
Proteins produced as described previously (Leppla, 1988) include wild-
type PA, FP59, and LF. Cytotoxicity assays for M2182 were performed
by treating cells at a concentration of 5 104 cells/well (in 6-well plates)
with PA (30 ng/ml) plus FP59 (50 ng/ml) for 2 days. Cells were cultured in
toxin-free medium for 3 days after toxin challenge before being stained
with crystal violet for microscope imaging and photography. For MTT
assay, cells were seeded in 96-well plates (100 ml/well) 1 day prior to
toxin treatment; the cell concentration used was 5  104 /ml for1152 Cell 124, 1141–1154, March 24, 2006 ª2006 Elsevier Inc.M2182 cell line and 3 104 /ml for RAW264.7 cell line. Various concen-
trations of PA combined with a fixed concentration of FP59 (50 ng/ml)
(for M2182 line) or LF (500 ng/ml) (for RAW264.7 line) were added to
wells, and cells were incubated for 48 hr at 37ºC. Cell viability was mea-
sured by adding 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium
bromide (MTT) (Sigma) to a final concentration of 1 mg/ml for 1 hr at
37ºC. The supernatant was carefully removed before the addition of
50 ml of solubilization solution (10% SDS in 0.01 N HCl) and subse-
quently of 200 ml of PBS to each well. Spectrophotometer readings at
570 nm were determined using a GENios Multi-Detection Reader
(TECAN, Phenix Research Products). Cell viability was normalized to
wells lacking PA. Each data point shown in figures for MTT assays rep-
resents the averaging of results from eight wells.
Preparation of LRP6-Specific Short Interfering RNAs
Three human-specific lrp6 sequences (tgctacgattgtagttgga, cgaatc
gaattgaggtgtc, tgtctcgaggtaaatcaat) and three murine-specific lrp6
sequences (gagaatgcaacgattgtag, gtgctttgtttaattgatc, atacacatctggtt
gagat) were selected. The siRNA duplexes were cloned into the
pLENTI-SUPER lentiviral vector (derived from pSUPER) (Brummel-
kamp et al., 2002). siRNA constructs were then introduced into cells
by infection. Stable clones of cells carrying siRNAs were selected us-
ing blasticidin (10 mg/ml) (Sigma). The scrambled siRNA control was
a product from Ambion (Austin, TX).
Assay for Luciferase Reporter Gene Activity and EGF
Receptor Degradation
These assays were performed as reported in (Veeman et al., 2003; Lu
et al., 2003) and described in detail in Supplemental Data.
Biochemical Assay of PA Binding and Internalization
Methods were as described by Liu et al. (2003a, 2003b), except that
the final concentration of PA and its incubation time were 0.05 mg/ml
for 2 hr and 1 mg/ml for 45 min, respectively.
Western Blotting and Coimmunoprecipitation
Western blotting was performed essentially as described by Harlow
and Lane (1999) using precast 10% or 3%–8% gels (Criterion XT Pre-
cast Gel, Bio-Rad) for electrophoresis and standard conditions. The
soluble cell proteins were quantitated using the BCA protein assay
kit (Pierce Biotechnology, Inc.). For coimmunoprecipitation assays,
293T cells, 48 hr after transfection, were lysed in NP40 buffer contain-
ing a protease inhibitor cocktail (Complete Mini, Roche Diagnostics,
Inc.). The lysates were centrifuged at 16,000  g, and the soluble frac-
tion was immunoprecipitated with the desired antibody-conjugated
agarose beads (Santa Cruz Biotechnology, Inc.). The cell medium
was included in LRP6N-Myc immunoprecipitation reactions because
LRP6N-Myc is secreted into the supernatant (Tamai et al., 2000) after
being expressed.
Antibody Reagents
Polyclonal antibody against PA was generated as described in Liu et al.
(2003b), and monoclonal antibody against PA was ordered from Novus
Biologicals (NB 600-407). Rabbit polyclonal antibody against human
LRP6 (H300) was purchased from Santa Cruz Biotechnology, Inc.,
and monoclonal anti-LRP5/6 antibody that was generated against
a synthetic peptide derived from an amino acid sequence (DTGT
DRIEVTR) of the second YWTD repeat of LRP6 was obtained from
A&G Pharmaceuticals (Baltimore, MD) and BioVision (Mountain View,
CA). Rabbit polyclonal antibodies N204 & N251 were generated for
us by Proteintech Group, Inc. (Chicago, IL) using synthetic peptides
derived from amino acid sequences (NFIHKSNLDGTNRQAVVKGS
for N204 and EVMNTDGTGRRVLVEDKIPH for N251). Agarose-conju-
gated monoclonal antibodies of c-Myc (9E10), HA (F-7), and GFP (B-2)
and horse radish peroxidase (HRP)-conjugated monoclonal antibodies
against c-Myc (9E10), HA (F-7), and GFP (B-2) were all obtained from
Santa Cruz Biotechnology, Inc. Anti-Flag (M2) monoclonal antibodies
against the HRP-conjugate and affinity gels used for co-IP experi-
ments were obtained from Sigma, Inc.
Immunofluorescence Microscopy
PA protein was labeled with Alexa Fluor 488 using the protein labeling
kit (A-10235, Molecular Probes, Inc.). The potency of PA after labeling
was fully retained as indicated by the MTT assay (data not shown). The
concentrations of PA-Alexa 488 used in analysis of PA binding and
processing were 0.6 mg/ml and 1 mg/ml, respectively. Immunostaining
was performed according to a standard protocol (Harlow and Lane,
1999). The primary antibody anti-Flag (M2) (murine monoclonal,
Sigma, Inc.) was used at a dilution of 1:200. Alexa-Fluor 594 goat
anti-mouse IgG (Molecular Probes) was used as the secondary anti-
body at a dilution of 1:400. The preconjugated antibody anti-HA-Alexa
Fluor-594 (murine monoclonal IgG1, 16B12, Molecular Probes) was
also used. The cover slips were mounted onto slides with a ProLong
Gold antifade reagent containing DAPI solution (Molecular Probes),
and cells were examined under a deconvolution microscope (Applied
Precision, Issaquah, WA).
Antibody Protection Assay
3  104/ml of RAW264.7 cells were first seeded in 96-well plates
(100 ml/well) the day prior to the assay. The cells were then incubated
at 37ºC for 48 hr with 3 ng/ml of PA, 500 ng/ml of LF, and serial dilutions
of antibodies. To test the specificity, the antibody was preabsorbed
with the N204 or the N251 peptide prior to assay. The antibody was
incubated with peptide in the ratio of 2 mg peptide /1 ml final bleed
on a rotator at 4ºC overnight, followed by a centrifugation at 14,000
RPM for 10 min to remove the precipitate. Toxin sensitivity was deter-
mined by the cell viability as described above.
Supplemental Data
Supplemental Data include Experimental Procedures and References
and can be found with this article online at http://www.cell.com/cgi/
content/full/124/6/1141/DC1/.
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